Medtronic PulseSelect system shows 100% acute success rate in AFib registry study
Bitget2026/10/22 11:05- Medtronic announced positive real-world registry results for its Sphere-9 catheter and PulseSelect ablation system, presented at APHRS 2026.
- The APEX registry found low major complication rates with Sphere-9 in atrial fibrillation patients, with similar safety across initial and repeat procedures.
- The REAL PULSE registry showed strong immediate procedural success with PulseSelect in atrial fibrillation patients, with few major complications.
- A separate APEX analysis showed promising ventricular tachycardia control with Sphere-9, though major complications occurred in some patients.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Market value evaporates by 23.6 billions USD, can AMD (AMD.US) earnings report end the bear market?
AMD's market value has shrunk from $1.06 trillion to $824 billion, dragged down by controversy over cyclical investment models and an industry-wide selloff. Although analysts expect revenue of $13 billion for the September quarter, bearish sentiment is strong in the options market, technical support levels have been breached, and the stock price faces further downside risk following the earnings release.

Shopify (SHOP.US) on the Eve of Earnings: Can the AI Monetization Logic Hedge against Valuation Correction?
Shopify's share price has retreated 13% from its yearly high, but Q2 revenue surged by 33.6% year-on-year. As its collaboration with Meta Muse deepens, the market is focusing on its AI monetization capabilities and whether it can meet the Q3 revenue expectation of $3.74 billions.


3 Catalysts Cramer Says Could Extend the Nasdaq Sell-Off This Week
